secwatch.observer — SEC 8-K summary
======================================

Issuer:     SELECT MEDICAL HOLDINGS CORP (SEM)
CIK:        0001320414
Form:       8-K
Filed at:   2024-10-31T23:59:59+00:00
Accession:  0001104659-24-113096
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Select Medical Q3 revenue up 5.7% to $1.76B; net income +33.2%; dividend $0.125; FY guidance updated
--------------------------------------------------------------------------------

- Q3 revenue $1,761.2M (+5.7% YoY); net income $81.0M (+33.2%); adjusted EPS $0.50 (+8.7%).
- Segment Adj. EBITDA: Critical Illness +9.5%, Rehab Hospital +12.1%, Concentra +2.7%.
- FY2024 guidance: revenue $6.95B–$7.15B; Adj. EBITDA $865M–$885M; adj. EPS $2.09–$2.20.
- Dividend $0.125/share declared, payable Nov 26 to holders of record Nov 13, 2024.
- No share repurchases in Q3; $600.3M total buybacks since program inception.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1320414/000110465924113096/0001104659-24-113096-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1320414/000110465924113096/tm2427100d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-113096

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer